Qingwu L. Yang

Guangyang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications

Quantification of microglial dynamic motility in vivo.

Quantification of microglial dynamic motility in vivo.

Journal: Biotechnic & histochemistry : official publication of the Biological Stain Commission
Published: August 24, 2026

Effect of Baseline ASPECTS on Tenecteplase Efficacy Before Thrombectomy in Acute Large-Vessel Occlusion Stroke: A Post Hoc Analysis of the BRIDGE-TNK Randomized Trial.

Effect of Baseline ASPECTS on Tenecteplase Efficacy Before Thrombectomy in Acute Large-Vessel Occlusion Stroke: A Post Hoc Analysis of the BRIDGE-TNK Randomized Trial.

Journal: Neurology
Published: August 20, 2026

Renoprotective effects of tubular glucagon receptor activation mediated by V-ATPase.

Renoprotective effects of tubular glucagon receptor activation mediated by V-ATPase.

Journal: Science advances
Published: August 05, 2026

Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke: The INSTANT Randomized Clinical Trial.

Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke: The INSTANT Randomized Clinical Trial.

Journal: JAMA
Published: May 08, 2026

Efficacy and safety of early tirofiban administration after intravenous thrombolysis in patients with acute ischaemic stroke: the multicentre, randomised, double-blind, placebo-controlled RESCUE BT3 trial protocol.

Efficacy and safety of early tirofiban administration after intravenous thrombolysis in patients with acute ischaemic stroke: the multicentre, randomised, double-blind, placebo-controlled RESCUE BT3 trial protocol.

Journal: European stroke journal
Published: April 01, 2026

GFAP+ FOXF2+ ependymal cells promote blood-brain barrier repair via DLL4-NOTCH signaling after neural injury.

GFAP+ FOXF2+ ependymal cells promote blood-brain barrier repair via DLL4-NOTCH signaling after neural injury.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 24, 2026

ADJUVANT Randomized Controlled Trial: Rationale and Design.

ADJUVANT Randomized Controlled Trial: Rationale and Design.

Journal: Journal of the American Heart Association
Published: March 04, 2026

Multiple Intracranial Nocardia brevicatena Abscesses in a Patient with a Previous History of Tuberculosis: A Case Report.

Multiple Intracranial Nocardia brevicatena Abscesses in a Patient with a Previous History of Tuberculosis: A Case Report.

Journal: Infection and drug resistance
Published: February 13, 2026

4-Dimethylaminophenol: A 'Smaller'-Molecule PPI Inhibitor Targeting the PSD95 GK Domain Against Ischemic Stroke.

4-Dimethylaminophenol: A 'Smaller'-Molecule PPI Inhibitor Targeting the PSD95 GK Domain Against Ischemic Stroke.

Journal: Angewandte Chemie (International ed. in English)
Published: January 16, 2026

Efficacy and safety of sublingual cilostazol and dexborneol for the treatment of acute ischaemic stroke: a randomised phase 2 trial in China.

Efficacy and safety of sublingual cilostazol and dexborneol for the treatment of acute ischaemic stroke: a randomised phase 2 trial in China.

Journal: EClinicalMedicine
Published: December 10, 2025

Stroke Etiologies With Intravenous Thrombolysis before Thrombectomy and Functional Outcomes in Anterior Circulation Large Vessel Occlusion.

Stroke Etiologies With Intravenous Thrombolysis before Thrombectomy and Functional Outcomes in Anterior Circulation Large Vessel Occlusion.

Journal: Annals of neurology
Published: December 10, 2025

5-methoxytryptamine improves hepatic inflammation and insulin resistance in a macrophage C-X-C motif chemokine ligand 14 dependent manner.

5-methoxytryptamine improves hepatic inflammation and insulin resistance in a macrophage C-X-C motif chemokine ligand 14 dependent manner.

Journal: Molecular biomedicine
Published: October 31, 2025
Showing 1-12 of 120

Last Updated: 09/26/2026